Search research articles
Contact Us
Filters
Showing results (21-30 of 101) with videos related to
Page
of 11
Sort By:
Journal of Addiction Medicine
|
October 30, 2024
Effects of Buprenorphine, Methadone, and Substance Use on COVID-19 Morbidity and Mortality
Nicholaus J Christian, Xin Zhou, Rajiv Radhakrishnan
JAMA Psychiatry
|
July 5, 2023
Substance Use Disorder and Health Outcomes in COVID-19-The Need for a Better Research Method to Determine Substance Use Exposure
Nicholaus J Christian, Xin Zhou, Rajiv Radhakrishnan
The Psychiatric Clinics of North America
|
May 6, 2023
Role of Psychedelics in Treatment-Resistant Depression
Shubham Kamal, Manish Kumar Jha, Rajiv Radhakrishnan
Mens Sana Monographs
|
June 2, 2012
Psychopharmacology of schizophrenia: The Future Looks Bleak
Chittaranjan Andrade, Rajiv Radhakrishnan, Praveen P Fernandes
The Journal of Clinical Psychiatry
|
May 16, 2019
Medical Marijuana: What Physicians Need to Know
Rajiv Radhakrishnan, Mohini Ranganathan, Deepak Cyril D'Souza
The Journal of Clinical Psychiatry
|
August 31, 2022
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
Divya Ramakrishnan, Soundari Sureshanand, Brian Pittman, et al.
The Journal of Clinical Psychiatry
|
August 26, 2016
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
Samuel T Wilkinson, Rajiv Radhakrishnan, Deepak Cyril D'Souza
Frontiers in Psychiatry
|
June 7, 2014
Gone to Pot - A Review of the Association between Cannabis and Psychosis
Rajiv Radhakrishnan, Samuel T Wilkinson, Deepak Cyril D'Souza
Indian Journal of Psychiatry
|
March 25, 2011
Standard operating procedures for clinical practice
T S Sathyanarayana Rao, Rajiv Radhakrishnan, Chittaranjan Andrade
Current Addiction Reports
|
March 14, 2015
Impact of Cannabis Use on the Development of Psychotic Disorders
Samuel T Wilkinson, Rajiv Radhakrishnan, Deepak Cyril D'Souza
Page
of 11
Search research articles
Search
Showing results (21-30 of 101) with videos related to
Sort By:
Page
of 11
Journal of Addiction Medicine
|
October 30, 2024
Effects of Buprenorphine, Methadone, and Substance Use on COVID-19 Morbidity and Mortality
Nicholaus J Christian, Xin Zhou, Rajiv Radhakrishnan
JAMA Psychiatry
|
July 5, 2023
Substance Use Disorder and Health Outcomes in COVID-19-The Need for a Better Research Method to Determine Substance Use Exposure
Nicholaus J Christian, Xin Zhou, Rajiv Radhakrishnan
The Psychiatric Clinics of North America
|
May 6, 2023
Role of Psychedelics in Treatment-Resistant Depression
Shubham Kamal, Manish Kumar Jha, Rajiv Radhakrishnan
Mens Sana Monographs
|
June 2, 2012
Psychopharmacology of schizophrenia: The Future Looks Bleak
Chittaranjan Andrade, Rajiv Radhakrishnan, Praveen P Fernandes
The Journal of Clinical Psychiatry
|
May 16, 2019
Medical Marijuana: What Physicians Need to Know
Rajiv Radhakrishnan, Mohini Ranganathan, Deepak Cyril D'Souza
The Journal of Clinical Psychiatry
|
August 31, 2022
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
Divya Ramakrishnan, Soundari Sureshanand, Brian Pittman, et al.
The Journal of Clinical Psychiatry
|
August 26, 2016
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
Samuel T Wilkinson, Rajiv Radhakrishnan, Deepak Cyril D'Souza
Frontiers in Psychiatry
|
June 7, 2014
Gone to Pot - A Review of the Association between Cannabis and Psychosis
Rajiv Radhakrishnan, Samuel T Wilkinson, Deepak Cyril D'Souza
Indian Journal of Psychiatry
|
March 25, 2011
Standard operating procedures for clinical practice
T S Sathyanarayana Rao, Rajiv Radhakrishnan, Chittaranjan Andrade
Current Addiction Reports
|
March 14, 2015
Impact of Cannabis Use on the Development of Psychotic Disorders
Samuel T Wilkinson, Rajiv Radhakrishnan, Deepak Cyril D'Souza
Page
of 11